Cetil

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cetil

What is Cetil: Foundational Overview and Identity

Property Description
Active ingredient Cefuroxime
Form Tablets, Oral Suspension, Powder for Injection
Pharmacological class Second-generation Cephalosporin Antibiotic
Common use Targeting Bacterial Infections
Origin Synthetic Compound

Defining Cetil: Classification and Core Identity

Cetil is a prescription-only medicine (Rx) brand containing the established generic substance Cefuroxime, a synthetic antibiotic belonging to the second-generation cephalosporin group. This classification defines it as a potent anti-infective agent. Cefuroxime is utilized to treat infections caused by susceptible organisms and possesses a broad spectrum of activity. The utility of Cefuroxime is clinically recognized for its efficacy in managing common respiratory tract and skin structure infections.

Active Ingredients, Forms, and Composition

The active ingredient is Cefuroxime, supplied in two principal forms to facilitate different routes of administration. For oral intake, such as tablets or the pediatric oral suspension, the substance is present as Cefuroxime axetil, a pro-drug designed for efficient gastrointestinal absorption. Conversely, the form utilized for parenteral delivery—by injection—is Cefuroxime sodium. Cetil is a single-ingredient product, containing only the Cefuroxime substance alongside necessary pharmaceutical excipients. The availability of a specially formulated liquid suspension marks a differentiating factor, as it allows for precise dosing and easier compliance among pediatric patients who cannot swallow solid tablets.

The Functional Principle: What Cefuroxime Does

The functional principle of Cefuroxime is that of a powerful bactericidal agent. This means its primary action is to actively destroy harmful bacteria by disrupting the synthesis of the bacterial cell wall, a structure critical for the pathogen's survival. A key differentiating feature is its stability against the beta-lactamase enzyme, which provides resistance against common bacterial defense mechanisms. This unique property allows Cefuroxime to remain effective against certain resistant strains that may fail to respond to older antibiotics.

Regulatory References

  1. FDA drug status and prescription requirements
  2. Cephalosporin Class Mechanism and Generations

What side effects are possible with Cetil?

Possible Side Effects and Safety Information

The official safety profile of Cetil (cefuroxime) is classified by regulatory authorities based on the frequency of documented adverse reactions. These reactions are grouped according to the specific System-Organ Classes (SOC) they affect, which typically include the Blood and Lymphatic System, Nervous System, Gastrointestinal Tract, and Skin.

Common adverse reactions, occurring in up to 1 in 10 patients, include diarrhea, headache, dizziness, nausea, and transient elevations in hepatic enzyme levels. Infections and Infestations, such as Candida overgrowth, are also listed as common. Uncommon reactions, occurring in up to 1 in 100 patients, include vomiting and various skin rashes.

Serious Adverse Reactions, which are often reported post-marketing and classified as frequency Not Known, require specific attention. These include severe allergic responses like anaphylaxis and rare but critical skin reactions such as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). The medication is also associated with Clostridioides difficile-associated diarrhea (CDAD), which can be severe and may occur up to two months after stopping treatment.

Safety notes specify that the serum half-life is prolonged in patients with renal impairment, necessitating caution. Furthermore, the use of cefuroxime is contraindicated in individuals with a known hypersensitivity to the drug or other beta-lactam antibacterial medicines due to the risk of cross-sensitivity. The drug can also interfere with certain laboratory tests, potentially causing a false-positive result in specific urine glucose tests and affecting blood cross-matching due to a documented positive Coombs test.

Overdose and Emergency Response

Overdose and When to Seek Help: Official Regulatory Information

Information concerning Cetil (cefuroxime) overdose is derived strictly from government-approved prescribing information. Immediate medical attention is required in the event of a suspected overdose. The official regulatory documents specify key manifestations and required actions.


Documented Overdose Manifestations

System Affected Manifestation Severe Outcome
Central Nervous System (CNS) Cerebral irritation Convulsions (Seizures)

Regulatory agencies note that overdosage of cephalosporins can lead to signs of cerebral irritation, with the potential for severe outcomes like convulsions.


Required Emergency Actions and Management

When to Seek Help: The official instruction is to "Get medical help right away" or "Seek medical attention immediately." Patients are also directed to contact a Poison Control center immediately if an overdose is suspected.

Antidote and Supportive Measures: No specific chemical antidote for Cefuroxime is listed in official labeling. Management is focused on symptomatic and supportive care. Procedures such as haemodialysis (hemodialysis) and peritoneal dialysis are officially documented as methods that can be used to reduce serum levels of Cefuroxime.

Population Consideration: Regulatory information highlights that the risk of drug accumulation and toxicity in an overdose scenario is increased for individuals with impaired renal function due to the slower elimination of the medication.

Therapeutic Uses of Cetil

What Cetil Treats: Main Uses and Benefits

Cetil (cefuroxime) is applied in addressing conditions where symptoms are related to susceptible bacterial infections across multiple domains. This medication is utilized for infections that cause noticeable physiological strain. It is relevant in clinical settings that involve acute or unstable symptom patterns, such as those seen in tonsillitis, bronchitis, pneumonia, sinusitis, otitis media, and uncomplicated urinary tract infections.

The medication is also applied when symptoms cluster into patterns requiring supportive management, including the management of cellulitis, impetigo, and early Lyme disease (Erythema Migrans). It is relevant for easing symptoms related to localized redness, swelling, and pain, and for managing symptoms associated with systemic imbalance like fever.

“It provides support that helps ease the overall symptom burden during episodes of heightened discomfort.”

The primary benefit is that the medication supports patients during difficult episodes by easing distress and helps maintain a sense of stability when symptoms are more noticeable. It is also used to help with prophylactic treatment to reduce the risk of infection following certain surgical procedures.


Quick Fact: Relief for Acute Respiratory Discomfort


Regulatory References

  1. NIH MedlinePlus overview of Cefuroxime

Eligibility and Restrictions for Use

Cetil is an antibiotic whose active ingredient is cefuroxime axetil, a cephalosporin. It is typically prescribed to treat various bacterial infections, including those of the respiratory tract, ear, sinus, urinary tract, and skin.

Who Can Use Cetil (Cefuroxime Axetil)?

Cetil is generally safe for use in patients with infections proven or strongly suspected to be caused by susceptible bacteria. Your doctor will determine if this medication is appropriate based on the type and severity of your infection, your age, and your overall health status.

Who Cannot Use Cetil?

Cetil is contraindicated (should not be used) in the following cases:

Condition Reason for Caution/Contraindication
Known Allergy/Hypersensitivity Patients with a known severe allergic reaction to cefuroxime axetil or any other cephalosporin antibiotic. It is also contraindicated in individuals with a history of severe immediate hypersensitivity to any beta-lactam antibiotic, such as penicillins or carbapenems, due to the risk of cross-reactivity and potentially life-threatening anaphylactic reactions.
Gastrointestinal Disease Use with caution in individuals with a history of colitis or severe diarrhea, as antibiotics, including Cetil, can alter the normal intestinal flora and potentially lead to Clostridioides difficile-associated diarrhea (CDAD).
Kidney Impairment Caution is advised in patients with kidney problems, as dose adjustments may be necessary to prevent accumulation of the drug in the body.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Cetil (Cefuroxime Axetil) is structured by documented interactions that modify the drug's systemic concentration and efficacy, as well as its effect on certain co-administered drugs.


Exposure Modification and Restrictions

Co-administration with Probenecid is officially not recommended because this agent slows renal tubular secretion, resulting in a documented increase in the systemic exposure and plasma concentration of Cefuroxime.

Drugs that reduce gastric acidity (e.g., antacids, H2-blockers, proton pump inhibitors) may lower the oral bioavailability of Cefuroxime Axetil. Therefore, the administration of short-acting antacids requires separation by at least one to two hours from the Cefuroxime dose.

Pharmacodynamic and Diagnostic Interference

Cefuroxime may affect the measurable effects of other drugs. Concurrent use with oral anticoagulants (like Warfarin) has been associated with an increased International Normalized Ratio (INR), reflecting a potentiated anticoagulant effect. Furthermore, the drug may reduce the efficacy of oral contraceptives due to documented effects on gut flora.

Cefuroxime also interferes with diagnostic procedures. Specifically, it causes a false-positive reaction for glucose in the urine when tested using copper reduction methods. Patients with renal impairment are noted to have slower excretion of the drug, leading to an increased systemic exposure risk. The oral suspension formulation contains phenylalanine, which is a documented constraint for patients with Phenylketonuria (PKU).

Mechanism of Action

The mechanism of Cetil is defined by its interference with biological processes within susceptible bacteria, leading to cellular lysis.


Targeted Lysis of the Bacterial Cell Wall

This domain covers the primary molecular interaction: Cefuroxime acts by covalently binding to and inactivating Penicillin-Binding Proteins (PBPs) —the enzymes responsible for cross-linking peptidoglycan. This inhibition arrests the final step of cell wall assembly, creating a structurally defective barrier. This mechanistic cascade leads to the osmotic rupture (lysis) and rapid destruction of the bacterial cell, resulting in the drug's bactericidal effect.


Built-in Resistance to Bacterial Defense

This domain addresses the drug's molecular stability against defense mechanisms. Cefuroxime's specific chemical configuration provides stability against many common beta-lactamase enzymes, which are bacterial proteins that typically attempt to chemically destroy the antibiotic. This stability ensures that the drug retains its active form at the target site, preventing the mechanism from being overridden and maintains the active concentration required for continued cellular lysis.

Dosage and Administration Information

How to use Cetil (Cefuroxime) — Official Administration Guidelines

Cetil (Cefuroxime) is administered via specific routes and schedules. The proper use of the medication is highly dependent on the chosen formulation (oral or parenteral) and adherence to timing instructions.


Administration Routes and Forms

Cetil is available for oral use as Cefuroxime axetil (tablets or liquid suspension) and for parenteral use (Intravenous or Intramuscular injection) as Cefuroxime sodium. The tablets (250 mg, 500 mg) and the oral suspension (125 mg/5 mL, 250 mg/5 mL) are not substitutable on a milligram-per-milligram basis.

Dosing and Frequency

Administration Type Standard Adult Frequency & Range Duration Pattern
Oral (Tablets) Typically 250 mg or 500 mg every 12 hours 7 to 10 days; 20 days for early Lyme disease
Parenteral (IV/IM) Typically 750 mg or 1.5 g every 8 hours Determined by clinical status, or a single dose for surgical prophylaxis

Administration Conditions

Specific instructions for administration conditions include:

  • Oral Suspension: Must be taken with food for optimum absorption. The suspension must be shaken well prior to each use.
  • Oral Tablets: May be taken with or without food. Tablets must be swallowed whole and should not be crushed or chewed.
  • Parenteral: Intramuscular injections should not exceed 750 mg at one site. IV administration may be a 3-to-5-minute bolus or a 30-to-60-minute infusion.

Population-Specific Use

For patients with impaired kidney function, the dosing interval must be adjusted to compensate for slower excretion; for example, patients with severely reduced renal function may take the medicine once daily. Pediatric dosing for the oral suspension is determined based on body weight.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Cetil


The core research supporting the activity of Cetil (Cefuroxime) primarily consists of Randomized Controlled Trials (RCTs). These short-term clinical studies are the standard format used to evaluate the medicine's activity against specific infections. In these studies, researchers often compared the medicine to another established antibiotic, exploring an approach known as non-inferiority testing (showing the medicine is not clinically worse than the comparator).

Regulatory bodies rely on evidence gathered across multiple large trials and Systematic Reviews. The goal of this research is to measure specific outcomes, such as the status of symptom response (clinical success) and the microbiological status of the specific bacteria. Studies have been conducted for acute respiratory infections like tonsillitis, Community-Acquired Pneumonia (CAP), and Acute Otitis Media (AOM), often including pediatric patients.

Cetil was also studied for uncomplicated infections, including skin and soft tissue infections (SSSI) and uncomplicated urinary tract infections (UTI). Research has also explored its role in surgical prophylaxis (prevention of infection) and for outcomes related to Early Lyme Disease (Erythema Migrans), where follow-up was extended over several months to track late-stage manifestations.

Despite the volume of research, certainty remains low in some areas. Key limitations include modest sample sizes in older adult studies, insufficient data for specific patient subgroups with comorbidities, and heterogeneity in outcomes across studies (e.g., for sinusitis). For many acute conditions, long-term effects and the durability of the microbiological response are not fully established, as the follow-up durations in the primary regulatory studies were limited.

Key Studies & References

  1. WHO Model List of Essential Medicines - Cefuroxime
  2. NICE Guideline: Lyme disease assessment and management

Frequently Asked Questions (FAQ)

Common questions about Cetil (FAQ)


Q: Is Cetil a brand name or the generic name for the medicine?

A: Cetil is a trade name for the medicine. The official active ingredient is Cefuroxime, specifically Cefuroxime axetil for the oral formulations. This is standard practice where the active drug is often marketed under various trade names.


Q: How does Cetil compare to other similar medications used for the same purpose?

A: Official information describes Cetil as belonging to the second-generation cephalosporin class of antibiotics. Its specific resistance profile and molecular structure are the basis for its role and differentiation from other types of antibacterial medicines.


Q: Is it normal to feel [vague side effect like 'a bit tired'] when you first start Cetil?

A: The regulatory adverse event documentation notes that general feelings of tiredness or drowsiness have been reported. While these effects are not classified among the most common adverse reactions, they may be experienced by some people.


Q: Is it necessary to avoid certain foods or drinks, such as grapefruit, while on Cetil?

A: The oral suspension formulation must be taken with food to ensure optimum absorption in the body. The official label also notes that the oral suspension contains phenylalanine, which is a constraint for patients with Phenylketonuria (PKU). No specific warning about grapefruit is routinely listed in the official product information.


Q: Will Cetil affect my ability to drive or operate machinery?

A: The official product information states that the medicine may cause side effects like dizziness or drowsiness. Because these effects could impair concentration, official labeling recommends caution when driving or operating machinery.


Q: What is the expected duration of action for a dose of Cetil?

A: Official pharmacokinetic data indicates that the drug has an elimination half-life of approximately 1 to 1.5 hours in people with normal kidney function. The prescribed frequency of the medicine is designed to maintain effective concentrations in the body.


Q: If I stop taking Cetil, how long will it stay in my system?

A: The drug is eliminated relatively quickly from the body, with a typical half-life (the time it takes for half the drug to be removed) of about 1 to 1.5 hours in people with normal kidney function. The majority of the drug is generally cleared from the body within several hours.


Q: Is Cetil generally considered safe for use in the elderly?

A: Official documents note that dosage adjustments are required for patients with impaired kidney function. The requirement for dosing adjustment or closer monitoring is a consideration for this population, as reduced kidney function is more common in the elderly.


Q: How does the body absorb and process Cetil (pharmacokinetics)?

A: Pharmacokinetic data shows that the oral form of Cetil is absorbed through the digestive tract. It is then predominantly excreted unchanged from the body via the kidneys (renal excretion).


Q: Can I take Cetil with my other regular medications?

A: The official product information lists documented interactions with several other medicines, including drugs that reduce stomach acid and oral anticoagulants. Official product information emphasizes the necessity of reviewing all co-administered medications with a healthcare professional.


Q: Why are there different strengths or forms of Cetil available?

A: Different forms (tablet, suspension, injection) and strengths are available to allow for the appropriate treatment of different types and severity of infections. This supports effective administration across different age groups and clinical needs.


Q: How is Cetil eliminated from the body?

A: Regulatory documentation states that Cetil is primarily eliminated unchanged from the body via the kidneys (renal excretion).


Q: Do I need any special monitoring or blood tests while taking Cetil?

A: The official product information notes that the drug can interfere with some lab tests, such as causing a false-positive Coombs test or interfering with certain urine glucose tests. Monitoring is often required for patients with pre-existing conditions, particularly kidney problems.


Q: How long do most people stay on Cetil for chronic conditions?

A: Cetil is typically prescribed for short-term (acute) bacterial infections, with common treatment durations lasting 7 to 10 days. There is no official dosage or duration schedule documented for chronic long-term use.


Q: Is Cetil in the same drug class as [Name of a common competitor drug]?

A: Official safety information classifies Cetil under the ATC code J01DC02, which identifies it as a second-generation cephalosporin antibiotic. This places it in the larger beta-lactam class of antibacterial medicines.


Q: Does Cetil cause any weight gain or weight loss?

A: Changes in body weight, including specific reports of weight loss, have been documented in the adverse reaction reports (post-marketing data). These are listed as events with an unknown incidence.


Q: Are there any known sexual side effects associated with Cetil?

A: A common documented side effect is the overgrowth of non-susceptible organisms, such as Candida (yeast) infections. These fungal infections can cause symptoms like vaginal itching or discharge.


Q: Can Cetil be used by women who are planning a pregnancy or are currently pregnant?

A: Official regulatory documents address the use of Cetil during pregnancy. Decisions regarding its use are typically made by a healthcare professional to weigh the potential risks and benefits in the specific situation.


Q: Does Cetil carry a risk of dependence or addiction?

A: Cetil is not scheduled under the Controlled Substances Act. Regulatory documents do not list it as a drug associated with risks of physical dependence or addiction.


Q: Why do some people stop taking Cetil before they finish the full course?

A: The official label warns that if the course is not completed as prescribed, there is a risk of developing drug-resistant bacteria and recurrence of the original infection.


Q: What happens if I miss a single dose of Cetil?

A: Regulatory documents contain specific guidance for managing a missed dose, typically advising consultation of the prescribed schedule to determine whether to take the dose immediately or skip it to avoid double dosing.


Q: Why is it important to take Cetil exactly as prescribed?

A: Taking the medicine exactly as prescribed ensures that the antibiotic concentration in the body remains high enough to consistently kill the target bacteria. This adherence supports successful treatment and helps prevent the development of drug-resistant bacteria.


Q: What is the risk of overdose if too much Cetil is taken?

A: Official documentation focuses on the documented symptoms, which may include excitation of the central nervous system and the possibility of seizures. Overdose treatment is typically managed with supportive care in a clinical setting.


Q: Can taking Cetil cause changes in blood pressure or heart rate?

A: Specific reports of changes in the cardiovascular system, such as episodes of low blood pressure and changes in heart rhythm, have been documented in post-marketing experience. These are listed as rare events often associated with severe allergic reactions.


Q: Are there different restrictions for using Cetil when breastfeeding?

A: Official information notes that low levels of Cetil pass into breast milk. While severe adverse effects are not typically expected, it may potentially cause side effects like diarrhea or thrush in the nursing infant. This information is provided for review by a healthcare professional to determine the appropriate course for the individual.


Q: Can Cetil cause drowsiness or insomnia?

A: The official list of adverse reactions includes drowsiness and dizziness as possible side effects. These central nervous system effects are categorized based on their frequency of occurrence in clinical use.


Q: What is the official safety classification of Cetil?

A: Official information classifies Cetil under the ATC code J01DC02, which is part of the anatomical therapeutic chemical classification system. This code identifies it as a second-generation cephalosporin antibiotic for systemic use.

How should Cetil be stored and disposed of?

How to Store and Dispose of Cetil

The storage and disposal of Cetil (Cefuroxime) are defined by official requirements to maintain its stability and ensure safety. Storage conditions vary significantly between the dry and liquid forms.


Official Storage Conditions

Formulation Temperature Requirement Protection / Handling
Tablets / Dry Powder Store at controlled room temperature (typically below 30 C). Keep in the original, tightly closed container, protected from light and moisture.
Reconstituted Suspension Store in a refrigerator (2 C to 8 C). Do not freeze. Must be discarded after 10 days.

Disposal and Safety Requirements

All forms of the medicine must be kept out of the sight and reach of children. Unused or expired Cetil must not be disposed of in household waste, drains, or by flushing. Disposal must be carried out in accordance with local regulations for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cetil found in:

A-Z Index: